Literature DB >> 21826025

Branch retinal vein occlusion during fingolimod treatment in a patient with multiple sclerosis.

Roberto Gallego-Pinazo, Enrique España-Gregori, Bonaventura Casanova, Diamar Pardo-López, Manuel Díaz-Llopis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21826025     DOI： 10.1097/WNO.0b013e31822bed20

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN： 1070-8022            Impact factor:   3.042


× No keyword cloud information.
  3 in total

Review 1.  Fingolimod: therapeutic mechanisms and ocular adverse effects.

Authors:  P Mandal; A Gupta; W Fusi-Rubiano; P A Keane; Y Yang
Journal:  Eye (Lond)       Date:  2016-11-25       Impact factor: 3.775

Review 2.  Ocular adverse events from pharmacological treatment in patients with multiple sclerosis-A systematic review of the literature.

Authors:  Juliana Muñoz-Ortiz; Juliana Reyes-Guanes; Estefanía Zapata-Bravo; Laura Mora-Muñoz; Juan Antonio Reyes-Hurtado; Luis Octavio Tierradentro-García; William Rojas-Carabali; Marcela Gómez-Suarez; Alejandra de-la-Torre
Journal:  Syst Rev       Date:  2021-10-28

3.  Diagnosis and Management of Fingolimod-Associated Macular Edema.

Authors:  Chunjiang Wang; Zhenzhen Deng; Liying Song; Wei Sun; Shaoli Zhao
Journal:  Front Neurol       Date:  2022-07-15       Impact factor: 4.086
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.